Search

Your search keyword '"Markova, Jana"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Markova, Jana" Remove constraint Author: "Markova, Jana" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
129 results on '"Markova, Jana"'

Search Results

2. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial

3. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

9. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

10. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

13. Probabilistic Analysis of Corrosion Rates and Degradation of Weathering Steel Bridges.

14. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

16. P047: Predictive role of the Hodgkin lymphoma-associated cytokines: a prospective study of the Czech Hodgkin Study Group

17. P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma

19. Uncertainties of Crack Width Models

21. Is It Better to Start Treatment with ABVD and Continue with PET2-Adapted Approach or Should We Use 2 Cycles of Beacopp Escalated and 2 Cycles of ABVD and Irradiation in Early Unfavorable Hodgkin Lymphoma?

27. Thermal design of structures and the changing climate

28. Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group

30. Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial

31. State of harmonised use of the Eurocodes

32. Preparing a European standard for ice loads on structures

35. The implementation of the Eurocodes in the National Regulatory Framework

36. High resolution biogenic global emission inventory for the time period 2000-2019 for air quality modelling.

37. Reliability of Structural Members Designed with the Eurocodes NDPs Selected by EU and EFTA Member States

39. Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma

40. Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group

44. Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study

45. Alternating R-CHOP and R-cytarabine is a safe and effective regimen for transplant-ineligible patients with a newly diagnosed mantle cell lymphoma

46. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials

48. New European Technical Rules for the Assessment and Retrofitting of Existing Structures

49. Reliability of existing clay masonry structures

50. Sulforaphane-induced apoptosis involves the type 1 IP3 receptor

Catalog

Books, media, physical & digital resources